Terms: = Uterine cancer AND NUTM2B, FAM22B, A6NNL0, 729262 AND Diagnosis
5 results:
1. Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal Sarcoma.
Kang N; Zhang Y; Guo S; Chen R; Kong F; Wang S; Yuan M; Chen R; Shen D; Wang J
Cancer Res Treat; 2023 Jul; 55(3):978-991. PubMed ID: 36731460
[TBL] [Abstract] [Full Text] [Related]
2. Undifferentiated uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.
Cotzia P; Benayed R; Mullaney K; Oliva E; Felix A; Ferreira J; Soslow RA; Antonescu CR; Ladanyi M; Chiang S
Am J Surg Pathol; 2019 May; 43(5):662-669. PubMed ID: 30789359
[TBL] [Abstract] [Full Text] [Related]
3. uterine epithelioid leiomyosarcoma with c-kit expression and YWHAE gene rearrangement: a case report of a diagnostic pitfall of uterine sarcoma.
Kubo T; Sugita S; Wada R; Kikuchi N; Iwasaki M; Ito Y; Sugawara T; Fujita H; Emori M; Tanaka R; Hirano H; Saito T; Hasegawa T
Diagn Pathol; 2017 Mar; 12(1):26. PubMed ID: 28288693
[TBL] [Abstract] [Full Text] [Related]
4. The application of next-generation sequencing-based molecular diagnostics in endometrial stromal sarcoma.
Li X; Anand M; Haimes JD; Manoj N; Berlin AM; Kudlow BA; Nucci MR; Ng TL; Stewart CJ; Lee CH
Histopathology; 2016 Oct; 69(4):551-9. PubMed ID: 26990025
[TBL] [Abstract] [Full Text] [Related]
5. YWHAE-FAM22 endometrial stromal sarcoma: diagnosis by reverse transcription-polymerase chain reaction in formalin-fixed, paraffin-embedded tumor.
Isphording A; Ali RH; Irving J; Goytain A; Nelnyk N; Hoang LN; Gilks CB; Huntsman DG; Nielsen TO; Nucci MR; Lee CH
Hum Pathol; 2013 May; 44(5):837-43. PubMed ID: 23159154
[TBL] [Abstract] [Full Text] [Related]
